Abstract: The present invention relates to methods for modulating endosomal GPCR signaling. In particular, the present invention relates to use of polymeric nanoparticles for the targeted delivery of hydrophobic modulators of endosomal GPCRs and their use in the treatment of associated diseases and disorder.

Abstract: The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl peptidases.

Abstract: Methods for improving immunoassays, and in particular, assays for B-Type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation are provided wherein one or more antibodies are selected such that the one or more antibodies detect a biologically active form of a natriuretic peptide of interest.

Abstract: The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl peptidases.

Abstract: The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl peptidases.

Abstract: The invention provides a process for remediation of sites contaminated with metals such as former industrial sites and mines. In particular the invention provides a process for site remediation comprising the steps of: (a) adding metal-binding particles to a site containing one or more metal contaminants such that at least some of the one or metal contaminants are sequestered by the particles, and (b) populating the site with plants. The use of the particles of the present invention in association with plants, and microbiota associated with the plant roots can achieve sustainable phytostabilization of contaminated sites.

Abstract: The invention provides a process for remediation of sites contaminated with metals such as former industrial sites and mines. In particular the invention provides a process for site remediation comprising the steps of: (a) adding metal-binding particles to a site containing one or more metal contaminants such that at least some of the one or metal contaminants are sequestered by the particles, and (b) populating the site with plants. The use of the particles of the present invention in association with plants, and microbiota associated with the plant roots can achieve sustainable phytostabilisation of contaminated sites.

Abstract: The present invention provides orthotic devices for use in managing the treatment and prevention of lower extremity injuries, including foot ulcers. In various aspects, the present invention provides foot-worn orthotics which provide for improved compliance monitoring, and methods of their manufacture and use.

Abstract: The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl peptide.

Abstract: The present invention describes compositions and methods for treating cardiovascular disease and myocardial infarction using dipeptidyl peptidase inhibitors. Also provided are methods for increasing natriuretic peptide function by administering one or more analogues of B type natriuretic peptide that provide increased stability in the presence of prolyl-specific dipeptidyl.

Abstract: The present invention provides improved methods for conducting living/controlled polymerization on polymeric solid supports. The improved methods allow polymerization to occur directly from the non-functionalized surface of a bulk support. In addition, polymerization may be re-initiated to provide co-polymers. The disclosed methods may employ the non-nitroxide-based RAFT and ATRP control agents that allow controlled polymerization to proceed at relatively low temperatures (<80° C.). Furthermore, these improved methods may provide graft polymers with decreased levels of “in-growth” of the bulk solid support. The invention also provides substrate polymers, with improved properties for solid phase synthesis and diagnostic applications, which may be made by the disclosed methods.

Abstract: The present invention relates generally to a polymer having co-continuous architecture. More particularly, the present invention is directed to a single or plurality of polymer layers in polymeric, co-polymeric, hybrid or blend formation comprising at least one polymer layer having co-continuous architecture. The co-continuous architecture of the one or more polymers permits or otherwise facilitates accessibility of functional groups to an external environment or at least one polymeric layer. The accessible, i.e. co-continuous, nature of the functional groups, in or on the one or more polymers facilitates solid phase chemical processes, chromatography and ion exchange applications. The one or more polymers may also be used as a solid support for a range of diagnostic applications.

Abstract: The present invention describes compositions and methods designed to determine the presence or amount of biologically active natriuretic peptides, or their fragments, in a sample. The degradation of natriuretic peptides is an ongoing process that may be a function of, inter alia, the elapsed time between onset of an event triggering natriuretic peptide release into the tissues and the time the sample is obtained or analyzed; the quantity of proteolytic enzymes present; etc. This degradation can produce circulating amounts of natriuretic peptides having reduced or lost biological function. The present invention provides, inter alia, assays designed to accurately measure biologically active natriuretic peptides, and compositions to inhibit a previously unknown pathway for degradation of natriuretic peptides.

Abstract: The present invention provides improved methods for conducting living/controlled polymerization on polymeric solid supports. The improved methods allow polymerization to occur directly from the non-functionalized surface of a bulk support. In addition, polymerization may be re-initiated to provide co-polymers. The disclosed methods may employ the non-nitroxide-based RAFT and ATRP control agents that allow controlled polymerization to proceed at relatively low temperatures (<80° C.). Furthermore, these improved methods may provide graft polymers with decreased levels of “in-growth” of the bulk solid support. The invention also provides substrate polymers, with improved properties for solid phase synthesis and diagnostic applications, which may be made by the disclosed methods.

Abstract: The present invention generally relates to polymers, including substrate polymers and hybrid polymers, having co-continuous architecture. The co-continuous architecture of the polymers of the present invention facilitates accessibility of functional groups to an external environment thereby making the polymers useful for a number of applications including solid phase chemistry, chromatography, and diagnostics. The present invention provides a number of methods for generating substrate polymers and hybrid polymers having co-continuous architecture including methods of grafting and macroporous formulation.

Abstract: A new Portable Cooling Kennel System for maintaining the temperature within a pet's kennel below a desired level thereby allowing the pet to travel with the owner on long trips, more particularly on airplane flights. The inventive device includes a typical kennel structure comprising a ventilation system, a sliding ice tray slidably projecting within the lower portion of the kennel structure, and at least one ice cartridge storage body for storing ice for cooling of the present invention.